Galenica Group has enhanced its Verfora Swiss consumer healthcare operation with the acquisition of phytotherapy and homeopathy specialist Spagyros for an undisclosed sum.
Slated to close in September, the deal will see Verfora acquire 100% of the share capital of Spagyros
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?